3.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PYXS Giù?
Forum
Previsione
Pyxis Oncology Inc Borsa (PYXS) Ultime notizie
Millennium Management LLC Reduces Stake in Pyxis Oncology Inc - GuruFocus
Is Pyxis Oncology Inc. stock a top pick in earnings seasonBear Alert & Verified Momentum Stock Alerts - Trung tâm Dự báo KTTV quốc gia
Smart tools for monitoring Pyxis Oncology Inc.’s price action2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
Developing predictive dashboards with Pyxis Oncology Inc. dataDay Trade & Low Risk Investment Opportunities - newser.com
Live market analysis of Pyxis Oncology Inc.2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
Full technical analysis of Pyxis Oncology Inc. stock2025 Trade Ideas & Reliable Intraday Trade Alerts - newser.com
Will Pyxis Oncology Inc. stock deliver better than expected guidance2025 Technical Overview & Smart Investment Allocation Tips - newser.com
Pyxis Oncology (NASDAQ:PYXS) Upgraded at Zacks Research - Defense World
Will Pyxis Oncology Inc. stock continue upward momentumEarnings Overview Summary & Weekly Breakout Stock Alerts - newser.com
How risky is Pyxis Oncology Inc. stock nowJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Why Pyxis Oncology Inc. stock is a value investor pickIPO Watch & Weekly High Return Opportunities - newser.com
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance
Strategies to average down on Pyxis Oncology Inc.Chart Signals & Reliable Price Action Trade Plans - newser.com
What makes Pyxis Oncology Inc. stock attractive to growth fundsQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com
Pyxis Oncology (PYXS) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance
Pyxis Oncology to Present Translational Data and Key - GlobeNewswire
ctDNA reduction in 37 clinical samples: Pyxis Oncology presents MICVO translational findings at ESMO & AACR 2025 - Stock Titan
Can Pyxis Oncology Inc. stock beat analyst upgradesTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Pyxis Oncology Gains 70%, Insider Trades Reap Benefit - 富途牛牛
Pyxis Oncology (NASDAQ:PYXS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Will Pyxis Oncology Inc. see short term momentumVolume Spike & Pattern Based Trade Signal System - newser.com
Is Pyxis Oncology Inc. stock undervalued vs historical averages2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Real time pattern detection on Pyxis Oncology Inc. stockMarket Growth Report & Community Consensus Picks - newser.com
Pyxis Oncology, Inc. Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets, Effective October 9, 2025 - MarketScreener
Pyxis Oncology appoints Alex Kane as SVP of investor relations By Investing.com - Investing.com Australia
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets - Quiver Quantitative
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):